BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38001699)

  • 1. Ring Chromosomes in Hematological Malignancies Are Associated with
    Boyd RJ; Murry JB; Morsberger LA; Klausner M; Chen S; Gocke CD; McCallion AS; Zou YS
    Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
    Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
    Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marker chromosomes can arise from chromothripsis and predict adverse prognosis in acute myeloid leukemia.
    Bochtler T; Granzow M; Stölzel F; Kunz C; Mohr B; Kartal-Kaess M; Hinderhofer K; Heilig CE; Kramer M; Thiede C; Endris V; Kirchner M; Stenzinger A; Benner A; Bornhäuser M; Ehninger G; Ho AD; Jauch A; Krämer A;
    Blood; 2017 Mar; 129(10):1333-1342. PubMed ID: 28119329
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Alkhatabi H; Yasin EB; Mirza Z; Alserihi R; Felimban R; Elaimi A; Shaabad M; Alharbi L; Ahmed H; Alameer AM; Mathkoor AE; Barefah AS
    Diagnostics (Basel); 2022 Mar; 12(3):. PubMed ID: 35328276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Karyotypic complexity, TP53 pathogenic variants, and increased number of variants on Next-Generation Sequencing are associated with disease progression in a North American Adult T-Cell Leukemia/Lymphoma cohort.
    Zhang X; Shi Y; Ramesh KH; Naeem R; Wang Y
    Int J Lab Hematol; 2021 Aug; 43(4):651-657. PubMed ID: 33988304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double minute chromosomes in acute myeloid leukemia and myelodysplastic syndromes are associated with complex karyotype, monosomal karyotype,
    Wang N; Yuan L; Jing Y; Fan K; Jin H; Lv C; Wang L; Yu L
    Leuk Lymphoma; 2021 Oct; 62(10):2466-2474. PubMed ID: 33904352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia.
    Becker H; Pfeifer D; Ihorst G; Pantic M; Wehrle J; Rüter BH; Bullinger L; Hackanson B; Germing U; Kuendgen A; Platzbecker U; Döhner K; Ganser A; Hagemeijer A; Wijermans PW; Döhner H; Duyster J; Lübbert M
    Ann Hematol; 2020 Jul; 99(7):1551-1560. PubMed ID: 32504186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute myeloid leukemia or myelodysplastic syndrome with chromosome 17 abnormalities and long-term outcomes with or without hematopoietic stem cell transplantation.
    Britt A; Mohyuddin GR; McClune B; Singh A; Lin T; Ganguly S; Abhyankar S; Shune L; McGuirk J; Skikne B; Godwin A; Pessetto Z; Golem S; Divine C; Dias A
    Leuk Res; 2020 Aug; 95():106402. PubMed ID: 32590108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ring chromosome in myeloid neoplasms is associated with complex karyotype and disease progression.
    Rosenbaum MW; Pozdnyakova O; Geyer JT; Dal Cin P; Hasserjian RP
    Hum Pathol; 2017 Oct; 68():40-46. PubMed ID: 28842184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent detection of targeted copy number variants and mutations using a myeloid malignancy next generation sequencing panel allows comprehensive genetic analysis using a single testing strategy.
    Shen W; Szankasi P; Sederberg M; Schumacher J; Frizzell KA; Gee EP; Patel JL; South ST; Xu X; Kelley TW
    Br J Haematol; 2016 Apr; 173(1):49-58. PubMed ID: 26728869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high prevalence of myeloid malignancies in progeria with Werner syndrome is associated with p53 insufficiency.
    Kato H; Maezawa Y; Nishijima D; Iwamoto E; Takeda J; Kanamori T; Yamaga M; Mishina T; Takeda Y; Izumi S; Hino Y; Nishi H; Ishiko J; Takeuchi M; Kaneko H; Koshizaka M; Mimura N; Kuzuya M; Sakaida E; Takemoto M; Shiraishi Y; Miyano S; Ogawa S; Iwama A; Sanada M; Yokote K
    Exp Hematol; 2022 May; 109():11-17. PubMed ID: 35240258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and molecular characteristics of acute myeloid leukemia and the dismal prognosis of
    Liu H; Shi Y; Tao S; Li Y; Wang C; Yu L
    Hematology; 2023 Dec; 28(1):2223866. PubMed ID: 37313982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Utility of Targeted Next-Generation Sequencing Assay to Detect Copy Number Variants Associated with Myelodysplastic Syndrome in Myeloid Malignancies.
    Jiang L; Pallavajjala A; Huang J; Haley L; Morsberger L; Stinnett V; Hardy M; Park R; Ament C; Finch A; Shane A; Parish R; Nozari A; Long P; Adams E; Smith K; Parimi V; Dougaparsad S; Long L; Gocke CD; Zou YS
    J Mol Diagn; 2021 Apr; 23(4):467-483. PubMed ID: 33577993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TET2 deletions are a recurrent but rare phenomenon in myeloid malignancies and are frequently accompanied by TET2 mutations on the remaining allele.
    Bacher U; Weissmann S; Kohlmann A; Schindela S; Alpermann T; Schnittger S; Kern W; Haferlach T; Haferlach C
    Br J Haematol; 2012 Jan; 156(1):67-75. PubMed ID: 22017486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical characteristics and therapeutic effect of TP53 variant in patients with acute leukemia].
    Mi R; Guo Z; Liu W; Hu J; Fan R; Chen L; Liu J; Wei X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Oct; 38(10):955-960. PubMed ID: 34625931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of chromosomal microarray and next generation sequencing to FISH and classical cytogenetics enhances genomic profiling of myeloid malignancies.
    Mukherjee S; Sathanoori M; Ma Z; Andreatta M; Lennon PA; Wheeler SR; Prescott JL; Coldren C; Casey T; Rietz H; Fasig K; Woodford R; Hartley T; Spence D; Donnelan W; Berdeja J; Flinn I; Kozyr N; Bouzyk M; Correll M; Ho H; Kravtsov V; Tunnel D; Chandra P
    Cancer Genet; 2017 Oct; 216-217():128-141. PubMed ID: 29025587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The detection of TP53 mutations in chronic lymphocytic leukemia independently predicts rapid disease progression and is highly correlated with a complex aberrant karyotype.
    Dicker F; Herholz H; Schnittger S; Nakao A; Patten N; Wu L; Kern W; Haferlach T; Haferlach C
    Leukemia; 2009 Jan; 23(1):117-24. PubMed ID: 18843282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TP53 mutations in myelodysplastic syndrome.
    Misawa S; Horiike S
    Leuk Lymphoma; 1996 Nov; 23(5-6):417-22. PubMed ID: 9031070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion.
    Sebaa A; Ades L; Baran-Marzack F; Mozziconacci MJ; Penther D; Dobbelstein S; Stamatoullas A; Récher C; Prebet T; Moulessehoul S; Fenaux P; Eclache V
    Genes Chromosomes Cancer; 2012 Dec; 51(12):1086-92. PubMed ID: 22933333
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.